The novel treatment of tirzepatide peptide represents a major development in the handling of diabetes mellitus type 2. Unlike existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide754547.blogars.com/40439618/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment